Will BMY's Oncology Collaborations Drive Its Next Growth Phase?
unknown
📅 Published: 2026-01-30 13:49
📰 Source: Yahoo
📝 Words: 20
📝 Article Content
BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.
📄 Summary
BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-01-30 20:35:29
Updated At:
2026-01-30 20:35:29
Scraping Job ID:
N/A
Stock Mentions:
BMY - [PLACEHOLDER] BMY
Relevance: N/A